Long-term effects of cholinergic basal forebrain lesions on neuropeptide Y and somatostatin immunoreactivity in rat neocortex by Gaykema, R.P.A. et al.
  
 University of Groningen
Long-term effects of cholinergic basal forebrain lesions on neuropeptide Y and somatostatin
immunoreactivity in rat neocortex





IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
1989
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Gaykema, R. P. A., Compaan, J. C., Nyakas, C., Horvath, E., & Luiten, P. G. M. (1989). Long-term effects
of cholinergic basal forebrain lesions on neuropeptide Y and somatostatin immunoreactivity in rat
neocortex. Brain Research, 489(2), 392-396. https://doi.org/10.1016/0006-8993(89)90878-0
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
392 Brain Research, 489 (1989) 392-396 
Elsevier 
BRE 23555 
Long-term effects of cholinergic basal forebrain lesions on 
neuropeptide Y and somatostatin immunoreactivity in rat neocortex 
R.P.A. Gaykema 1, J.C. Compaan 1, C. Nyakas 1, E. Horvath  2 and P .G .M.  Lu i ten  1 
~ Department of Animal Physiology, University of Groningen, Haren (The Netherlands) and eNeurobiology Department, 
Troponwerke, Cologne (E R. G. ) 
(Accepted 28 February 1989) 
Key words: cholinergic basal forebrain lesion; Somatostatin; Neuropeptide Y; Neocortex; Rat 
The effect of cholinergic basal forebrain lesions on immunoreactivity to somatostatin (SOM-i) and neuropeptide-Y (NPY-i) was 
investigated in the rat parietal cortex, 16-18 months after multiple bilateral ibotenic acid injections in the nucleus basalis complex, 
As a result of the lesion, the cholinergic fiber density in the cortex decreased by 66% with a concurrent increase in SOM-i fibers 
by more than 50% and a 124% increase in NPY-i fiber innervation. The neuropeptidergic sprouting response on cholinergic 
denervation does not match the concurrent cholinergic and peptidergic decline in Alzheimer's disease and as such does not support 
the cholinergic lesion alone as an animal model for this neurodegenerative disorder. 
The systemic breakdown of the magnocellular 
basal forebrain complex, which is the subcortical 
source of cholinergic innervation of cortex and 
hippocampus ~6"]8, is the most consistent transmitter- 
specific change found in Alzheimer's disease (AD). 
These findings led to the cholinergic hypothesis for 
dementia, which assumes a major role of specific 
cholinergic decline of the basal forebrain system in 
the causation of the neuropathology found in Alz- 
heimer's disease 2'6 and its characteristic mpairment 
of learning and memory. Ever since, a large number 
of studies were initiated on experimental cholinergic 
basal forebrain lesions in search for an animal model 
for this neurodegenerative disorder j'7'~3'15'2°~22 To 
validate the cholinergic forebrain lesion as a demen- 
tia model, or in general to study complex learning- 
memory functions of the forebrain, this experimen- 
tal model should meet several criteria. First, cholin- 
ergic forebrain lesions should mimic the persistent 
amnesic deficits characteristic for the dementia 
syndromes. Indeed, experimental damage to the 
magnocellular basal nucleus and the medial septal 
area under certain conditions results in a permanent 
deterioration of the performance of animals in a 
variety of learning and memory tasks 13-15"2°'22. Sec- 
ond, the specific cholinergic forebrain lesion should 
lead to similar biochemical and anatomical effects in 
cortex and hippocampus which define the neuropa- 
thoiogy in AD. In this respect, several neurotran- 
smitter and neuropeptidergic systems in the cortical 
mantle appear to be affected 3'4'9. For neuropeptides 
there is ample evidence that somatostatin (SOM) 
and neuropeptide Y (NPY) systems in cortex and 
hippocampus are severely damaged and involved in 
the formation of neurofibrillary tangles and neuritic 
plaques 3~4"~. In the present investigation we aimed at 
assessing whether the concurrent cholinergic and 
peptidergic decline in AD are causally related or 
independent degenerative phenomena. In the cur- 
rently used experimental design the cholinergic 
lesion and prolonged cortical cholinergic denerva- 
tion was obtained by multiple injections in the 
magnocellular basal forebrain complex (MBN) with 
the excitotoxin ibotenic acid, followed by extended 
survival periods of 16-18 months. In our view such 
long-term effects of cholinergic lesions into the aging 
stage of the experimental animal bear more resem- 
blance to the human neuropathology. From recent 
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Fig. 1. Photomicrographs of layers 2-5 of the parietal cortex stained for AChE (A and D), with dark-field illumination, NPY (B 
and E) and SOM (C and F). The upper ow (A-C) represents the control condition with intact cholinergic innervation and 
concomitant moderate normal fiber density of SOM-i and NPY-i. D-F illustrate comparable cortex layers in an MBN lesioned case 
with strong decline of cholinergic fibers (D) and concurrent increased immunoreactivity of NPY and SOM. Figures 2-5 refer to 
cortical layers. Bar = 100/~m. 
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studies it may indeed be concluded that certain 
effects of cholinergic lesions only become manifest 
after long survival periods, while remaining unno- 
ticed shortly after experimental damage 1.
The data presented here on acetylcholinesterase 
(AChE)-positive, and on SOM- and NPY-immuno- 
reactive fiber innervation i  the neocortex are based 
on 4 MBN-lesioned and 6 sham-operated male 
albino Wistar rats. The lesions were performed at 
the age of 10 months by 5 bilateral pressure 
injections of 0.5/~1 ibotenic acid (1 mg/ml in saline, 
pH = 7.421) in the MBN using stereotaxic proce- 
dures and according to the following coordinates 
(relative in mm to interaural point). 
1 2 3 4 5 
A-P  6.3 6.3 7.3 7.3 8.3 
L -R + 4.3 + 4.3 + 3.6 + 3.0 + 2.5 
D-V 2.6 3.4 3.8 2.6 1.8 
The sham-operated animals received rilled holes 
in the skull at the appropriate coordinates and 
served as controls. Before histological treatment the 
animals underwent extensive behavioral testing. All 
lesioned cases revealed persistent learning/memory 
deficits as reported elsewhere 13. At 16-18 months 
after lesioning, the animals were transcardially per- 
fused briefly with saline, followed by a fixative 
solution of 3% paraformaldehyde and 0.01% glutar- 
aldehyde in 0.05 M phosphate buffer, pH 7.4. The 
brains were cut at 20/~m transverse sections on a 
cryostat microtome after overnight dehydration in 
30% sucrose at 4 °C. Every eighth section was 
postfixed overnight in buffered 2.5% glutaraldehyde 
and stained for AChE according to the procedure of 
Hedreen et al. 11. The Hedreen method combined 
with glutaraldehyde postfixation yields crisply 
stained AChE-positive fibers against a pale yellow- 
ish background. Adjacent sections were processed 
for immunocytochemical identification of SOM and 
NPY, respectively (Fig. 1). Both for SOM and NPY 
immunostaining the following incubation steps were 
carried outS: preincubation in 10% normal goat 
serum, primary antibody incubation (rabbit anti- 
SOM 28, 1:2000 or rabbit anti-NPY, 1:1500) for 72 
h at 4 °C, a second incubation in goat anti-rabbit IgG 
(Nordic, 1:50) overnight at 4 °C and a final exposure 
to rabbit peroxidase-antiperoxidase complex (DA- 
KO, 1:500) again overnight at 4 °C. The peroxidase 
was visualized by standard processing with DAB and 
hydrogen peroxide. 
The relative density of AChE-positive, SOM-i 
(-immunoreactive) and NPY-i fibers was assessed in 
the parietal cortex area 124 at 3 anterior-posterior 
levels (-0.3, -0.8 and -1.3 mm relative to Breg- 
ma24). Quantification of the fibers was performed by 
projecting the sections via a drawing tube of the 
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AVE I II III AVE  I II III AVE  
fiber density in 3 sublayers ofthe parietal neocortex ascounted by fibers crossing a line pattern 
in a grid of 240 × 240 gm (see text). Open bars represent control cases, hatched bars the cases lesioned in the MBN. I-III indicates 
the 3 cortical sublayers counted (see text) and AVE the average of the 3 sublayers. Asterisk indicates statistical significance 
calculated with the Mann-Whitney U-test at P < 0.05. 
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horizontal and 5 vertical lines according to the 
method described by Stichel and Singer 23. With the 
magnification used, the grid measured 240 x 240 ~m 
and was projected upon 3 radially oriented positions 
(I, II and III in Fig. 2) corresponding to layers 2 and 
3 (I), layers 4 and superficial layer 5 (II), and deep 
layer 5 and 6 (III) of the parietal cortex. The relative 
fiber density was established by counting the cross- 
ing of fibers with the horizontal and vertical ines of 
the grid. The counts for each of the three grid 
positions were averaged over the three A-P levels 
and the S.E.M.'s calculated. All quantifications of
cholinergic and peptidergic fibers were compared 
between the lesioned and the control groups. Dif- 
ferences were analyzed for statistical significance by 
the Mann-Whitney U-test. Significance was assumed 
for P < 0.05. 
All lesioned cases studied showed a remarkably 
stable pattern of decrease of AChE-positive fibers 
and a concurrent increase of both SOM-i and NPY-i 
axonal abeling in all cortical ayers examined (Fig. 
2). The normal cholinergic innervation pattern as 
demonstrated byAChE histochemistry is completely 
similar to the pattern of choline acetyltransferase 
immunoreactivity 17. It is characterized by relatively 
dense fiber networks in layers 1, 2 and 3, a loose 
pattern in layer 4, a dense innervation in layer 5, 
slightly decreasing in layer 6. After MBN lesion, all 
layers showed a very strong decline in cholinergic 
fibers. This decline was calculated as an average for 
all cortical layers of 66% and was highest for the 
superficial layers 2 and 3 (Fig. 2). The consistency of 
this decline is illustrated by the low S.E.M. values. 
In contrast o the cholinergic denervation, there is a 
strong and equally consistent increase in SOM-i and 
NPY-i fibers. The relative density of SOM-i axons 
increased with an average of 51%, whereas an 
average of 124% more NPY-i fibers were counted in 
the lesioned cases. All figures showed moderate 
S.E.M. levels and were statistically significant. Fur- 
thermore, the degree of decrease of cholinergic 
denervation i the different cortical sublayers I-II I 
seemed to be proportional to the level of increase in 
peptidergic fibers. Thus, the strongest decrease of 
cholinergic innervation in cortical ayers 2 and 3 is 
accompanied by the highest increase in both neuro- 
peptides' immunoreactivity. 
The present findings clearly indicate highly sig- 
nificant increases in SOM-i and NPY-i fibers after 
long-term cholinergic denervation i the neocortex. 
As such, our data corroborate the observations of 
Arendash et al. 1, who, with biochemical assays, 
found increases in SOM and NPY concentrations of 
138 and 284%, respectively, 14 months after partial 
MBN lesions. The SOM-i and NPY-i increment after 
MBN lesion, however, appears to be related to the 
length of the post-lesion survival time. Our own 
unpublished observations on SOM-i and NPY-i 
fibers two weeks after MBN lesion do not show any 
significant change compared to controls. These 
findings are consistent with several previous reports 
on persistent peptidergic innervation levels up to 6 
months after MBN lesioning 1'7'9'19. H6rtnagl and 
Sperk ~2 reported on short-term changes in SOM- 
and NPY levels after cholinergic lesions which, 
however, returned to normal control evels after two 
week postlesion time. 
The increased presence of SOM-i and NPY-i fiber 
networks may well be interpreted as a long-term 
heterotypic sprouting response of the intrinsic pep- 
tidergic innervation as a result of cholinergic dener- 
vation of the neocortex. However, since the peptides 
were demonstrated with immunocytochemical detec- 
tion methods, we cannot exclude that the increased 
fiber density is the result of higher peptide concen- 
trations in existing fibers which remain under the 
sensitivity threshold in the control cases. The latter 
explanation, however, seems unlikely since in all 
tissue sections studied the immunoprecipitate ap- 
peared crisply and strongly stained and not subject 
to a sensitivity gradient (see also Fig. 1). It appears 
more likely that cholinergic denervation on the 
long-term and possibly combined with aging-related 
factors, leads to heterotypic sprouting outgrowth of 
SOM-i and NPY-i axon collaterals. This, however, is 
in striking contrast with the simultaneous deteriora- 
tion of cholinergic and peptidergic innervation ob- 
served in Alzheimer's disease. In that sense, the 
MBN lesion model in experimental nimals uggests 
that a cholinergic denervation alone is unlikely to 
cause a decline of the peptidergic systems in the 
cortex of AD patients. Furthermore, it should be 
noted that currently used MBN lesion models are all 
based on a sudden, momentary destruction of MBN 
cells. A more gradual extinction of the cholinergic 
cortical innervation by a chronical excitotoxin lesion 
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model may better mimic the neuropathology occur- 
ring in AD. In summary, although the experimental 
cholinergic lesion shows a considerable analogy to 
the behavioral deficits in learning and memory in 
AD, the anatomical substrates underlying the hu- 
man neuropathology remain to be understood. 
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